An experimental weight-loss drug produced by Vivus, Incorporated recently met U.S. guidelines in two late-stage trials. The proven effectiveness of the new obesity drug, known as Qnexa, has paved the way for Vivus to seek regulatory approval from the U.S. Food and Drug Administration (FDA).
(more…)